Breaking News Instant updates and real-time market news.

NVDA

Nvidia

$209.88

1.33 (0.64%)

18:04
11/14/19
11/14
18:04
11/14/19
18:04

Nvidia CEO says Q4 will be much stronger driven by AI and inference

Says computational intensity is "so high" that, aside from computer graphics, only accelerators make the work loads possible. Comments taken from Q3 earnings conference call Q/A.

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

NVDA Nvidia
$209.88

1.33 (0.64%)

11/11/19
DBAB
11/11/19
NO CHANGE
Target $190
DBAB
Hold
Nvidia price target raised to $190 from $160 at Deutsche Bank
Deutsche Bank analyst Ross Seymore raised his price target for Nvidia to $190 from $160 ahead of the company's Q3 results and keeps a Hold rating on the shares. With the stock up 30% since the company's last earnings report, investors are expecting a "solid beat/raise heading into earnings," Seymore tells investors in a research note. He sees potential for "modest" upside relative to expectations but believes "much of this goodness is already reflected in the shares."
11/12/19
OPCO
11/12/19
NO CHANGE
Target $250
OPCO
Outperform
Nvidia price target raised to $250 from $190 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Nvidia to $250 from $190 ahead of its quarterly earnings, saying he expects a beat and raise set up for Q3. In a research note to investors, Schafer, who maintains an Outperform rating, says he sees upside led by continued post-crypto rebound in core gaming as well as improved hyperscaler spend on DC/Cloud and adds that he remains a buyer of Nvidia, as the company appears positioned to capitalize on long-term secular trends in DC, high performance gaming, and autonomous vehicles.
11/12/19
SUSQ
11/12/19
NO CHANGE
Target $240
SUSQ
Positive
Nvidia price target raised to $240 from $190 at Susquehanna
Susquehanna analyst Christopher Rolland raised his price target for Nvidia (NVDA) to $240 from $190 ahead of the company's Q3 results on November 14. While difficult to make a clear call on the quarter, this is the first time in many quarters that expectations are generally in-check with typical seasonality, Rolland tells investors in a pre-research note. He points out that Nvidia in the quarter refreshed its high-end RTX cards to combat the 7nm graphics processing unit launch from AMD (AMD). While AMD was able to gain modest share in aftermarket graphics cards during the quarter and is now rumored to be launching a lower-priced Navi GPU to compete in the midrange, the analyst believes Nvidia will take back most lost share on the release of 7nm next year. With the company facing "the most reasonable Street expectations in quite some time," Rolland reiterates a Positive rating on Nvidia.
11/14/19
BMOC
11/14/19
NO CHANGE
Target $200
BMOC
Market Perform
Nvidia price target raised to $200 from $145 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Nvidia to $200 ahead of its Q3 earnings later today, saying the setup going into the print is "relatively positive" with a "cleaned up" supply chain in the Gaming segment and recovery among other chip companies supporting expectations for the Data Center segment. The analyst adds that he is "playing catch-up" with the target price but also maintains his Market Perform rating, noting that the stock is reasonably valued at current levels.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$331.33

-0.68 (-0.20%)

15:10
01/21/20
01/21
15:10
01/21/20
15:10
Hot Stocks
CDC confirms first travel-related case of 2019 coronavirus in U.S. »

The Centers for Disease…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$331.33

-0.68 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Therapeutics

$38.25

-0.16 (-0.42%)

15:06
01/21/20
01/21
15:06
01/21/20
15:06
Hot Stocks
Horizon Therapeutics announces FDA approves Tepezza for TED »

Horizon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

AMZN

Amazon.com

$1,867.66

3.26 (0.17%)

15:06
01/21/20
01/21
15:06
01/21/20
15:06
Periodicals
Amazon files international trademarks for 'Amazon Pharmacy,' CNBC reports »

Amazon (AMZN) acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jan

  • 30

    Jan

  • 10

    Feb

GOOGL

Alphabet Class A

$1,479.59

0.47 (0.03%)

, FB

Facebook

$220.86

-1.15 (-0.52%)

15:04
01/21/20
01/21
15:04
01/21/20
15:04
Conference/Events
SunTrust technology analysts to hold an analyst/industry conference call »

Analysts, along with…

GOOGL

Alphabet Class A

$1,479.59

0.47 (0.03%)

FB

Facebook

$220.86

-1.15 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

  • 03

    Feb

  • 10

    Feb

IBM

IBM

$138.89

0.58 (0.42%)

15:04
01/21/20
01/21
15:04
01/21/20
15:04
Options
IBM options imply 7.6% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

PSXP

Phillips 66 Partners

$63.04

-0.94 (-1.47%)

15:00
01/21/20
01/21
15:00
01/21/20
15:00
Hot Stocks
Phillips 66 Partners raises quarterly distribution 5% to 87.5c per unit »

Phillips 66 Partners LP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

AAPL

Apple

$316.65

-2.01 (-0.63%)

, SPOT

Spotify

$149.14

0.935 (0.63%)

14:58
01/21/20
01/21
14:58
01/21/20
14:58
Periodicals
Apple discussing podcasts with producers of TV+ shows, Bloomberg says »

Apple's (AAPL) move…

AAPL

Apple

$316.65

-2.01 (-0.63%)

SPOT

Spotify

$149.14

0.935 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 05

    Feb

HZNP

Horizon Therapeutics

$37.79

-0.62 (-1.61%)

14:53
01/21/20
01/21
14:53
01/21/20
14:53
Hot Stocks
FDA approves Horizon Therapeutics' Tepezza for thyroid eye disease »

The U.S. Food and Drug…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

HZNP

Horizon Therapeutics

$37.79

-0.62 (-1.61%)

14:52
01/21/20
01/21
14:52
01/21/20
14:52
Hot Stocks
Breaking Hot Stocks news story on Horizon Therapeutics »

FDA approves Horizon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

14:50
01/21/20
01/21
14:50
01/21/20
14:50
General news
Canada Market Summary »

Canada Market Summary:…

QD

Qudian

$3.39

-0.12 (-3.42%)

14:49
01/21/20
01/21
14:49
01/21/20
14:49
Downgrade
Qudian rating change  »

Qudian downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$306.21

-17.9 (-5.52%)

14:49
01/21/20
01/21
14:49
01/21/20
14:49
Hot Stocks
Breaking Hot Stocks news story on Boeing 

Boeing trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

NFLX

Netflix

$333.90

-5.66 (-1.67%)

14:49
01/21/20
01/21
14:49
01/21/20
14:49
Options
Netflix options imply 12.1% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

AMT

American Tower

$237.09

3.73 (1.60%)

14:45
01/21/20
01/21
14:45
01/21/20
14:45
Options
American Tower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENZ

Enzo Biochem

$2.54

-0.095 (-3.61%)

14:42
01/21/20
01/21
14:42
01/21/20
14:42
Hot Stocks
Proxy advisory firms urge shareholders to vote for Enzo Biochem board changes »

Harbert Discovery Fund,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

NVAX

Novavax

$8.64

2.895 (50.39%)

14:40
01/21/20
01/21
14:40
01/21/20
14:40
Periodicals
Novavax developing coronavirus vaccine candidate, Bloomberg says »

A third-party…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$23.93

0.02 (0.08%)

14:38
01/21/20
01/21
14:38
01/21/20
14:38
Upgrade
iQIYI rating change  »

iQIYI upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

NFLX

Netflix

$334.85

-4.71 (-1.39%)

14:36
01/21/20
01/21
14:36
01/21/20
14:36
Technical Analysis
Technical Earnings Preview: Netflix »

The stock is trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

BA

Boeing

$306.21

-17.9 (-5.52%)

14:36
01/21/20
01/21
14:36
01/21/20
14:36
Hot Stocks
Boeing sees ungrounding of 737 MAX to begin during mid-2020 »

Boeing issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$306.21

-17.9 (-5.52%)

14:34
01/21/20
01/21
14:34
01/21/20
14:34
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing currently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

PSN

Parsons

$42.71

0.75 (1.79%)

14:34
01/21/20
01/21
14:34
01/21/20
14:34
Hot Stocks
Parsons awarded contract from GSA for cyber space engineering »

Parsons Corporation has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QD

Qudian

$3.43

-0.085 (-2.42%)

14:32
01/21/20
01/21
14:32
01/21/20
14:32
Downgrade
Qudian rating change  »

Qudian downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBHT

J.B. Hunt

$116.15

1.38 (1.20%)

14:27
01/21/20
01/21
14:27
01/21/20
14:27
Recommendations
J.B. Hunt analyst commentary  »

J.B. Hunt price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

BX

Blackstone

$61.57

0.78 (1.28%)

, OAK

Oaktree Capital

$0.00

(0.00%)

14:26
01/21/20
01/21
14:26
01/21/20
14:26
Periodicals
Global investment firms 'swoop' in to buy defaulted Chinese loans, WSJ says »

Global investment firms…

BX

Blackstone

$61.57

0.78 (1.28%)

OAK

Oaktree Capital

$0.00

(0.00%)

BCSF

Bain Capital Specialty Finance

$19.67

-0.015 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 04

    Feb

  • 26

    Feb

  • 27

    Feb

MLCO

Melco Resorts & Entertainment

$22.73

-2.28 (-9.12%)

14:25
01/21/20
01/21
14:25
01/21/20
14:25
Options
Melco Resorts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.